Pricing Log in Create free account

Boundless Bio, Inc. (BOLD) vs Rein Therapeutics Inc. (RNTX)

Boundless Bio, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Boundless Bio, Inc. and Rein Therapeutics Inc. are of similar size ($54.2M and $53.5M). Across the 8 metrics below, Boundless Bio, Inc. leads on 5 and Rein Therapeutics Inc. on 3.

Valuation

Metric BOLD RNTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.80 3.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.03 0.64
EV/Sales n/m n/m 9.21
Earnings yield (122.22%) (291.53%) (33.15%)
Free cash flow yield (107.99%) (47.32%) (25.50%)

Profitability

Metric BOLD RNTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.86%) (753.55%) (56.36%)
Return on assets (50.56%) (80.62%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BOLD RNTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 32.47% 44.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BOLD RNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.48 4.27 4.72
Net debt to EBITDA 0.99 0.15 0.96

Dividend

Metric BOLD RNTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BOLD RNTX Biotechnology median
Market cap 53.46m 54.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack